Milicevic Mihailo, Solari Domenico, Illic Rosanda, Frio Federico, Stanimirovic Aleksandar, Savic Dragan, Somma Teresa, Cavallo Luigi Maria, Grujicic Danica
Medical Faculty University of Belgrade, Clinical Center of Serbia, Clinic of Neurosurgery, Belgrade, Serbia.
Turk Neurosurg. 2020;30(2):252-262. doi: 10.5137/1019-5149.JTN.27471-19.2.
To analyze the impact of intraoperative neurophysiological monitoring (IONM) on the extent of removal and long-term neurological outcomes in a series of grade II ependymomas.
We retrospectively reviewed 88 consecutive patients who underwent surgical resection of an intramedullary spinal cord tumor (IMSCT) at the Clinic of Neurosurgery of the Clinical Center of Serbia in Belgrade between January 2012 and December 2017. In all, 39 patients (25 males and 14 females; mean age 46.16 years) with grade II ependymomas were enrolled in this study; the mean follow-up time was 49.84 months. The modified McCormick Scale (mMCS) was used to assess the short- and long-term outcomes, and the patients were divided into two groups based on whether they underwent IONM.
The gross-total removal rate was 89.7%, and it was not influenced by use of IONM, location or tumor size. Upon admission,43.2% of the patients were dependent (grades IV and V), while 56.8% were independent (grades I, II and III), according to the mMCS. After 3 months of follow-up, 76.9% of the patients maintained or improved their neurological status, but this percentage was reduced after long-term follow-up.
Total surgical resection with good neurological outcomes can be achieved in the vast majority of patients with grade II ependymomas; it is important to emphasize that the use of IONM allows acceptable extent of resection and provides better results in terms of functional outcomes, with lower morbidity rates. Therefore, no correlation was demonstrated between the decrease in the basal amplitudes of IONM and D-waves and poor neurological outcomes.
分析术中神经生理监测(IONM)对一系列Ⅱ级室管膜瘤切除范围及长期神经功能预后的影响。
我们回顾性分析了2012年1月至2017年12月期间在贝尔格莱德塞尔维亚临床中心神经外科诊所接受髓内脊髓肿瘤(IMSCT)手术切除的88例连续患者。本研究共纳入39例Ⅱ级室管膜瘤患者(25例男性和14例女性;平均年龄46.16岁);平均随访时间为49.84个月。采用改良麦考密克量表(mMCS)评估短期和长期预后,并根据患者是否接受IONM将其分为两组。
全切除率为89.7%,不受IONM的使用、肿瘤位置或大小的影响。入院时,根据mMCS,43.2%的患者依赖(Ⅳ级和Ⅴ级),而56.8%的患者独立(Ⅰ级、Ⅱ级和Ⅲ级)。随访3个月后,76.9%的患者神经功能状态维持或改善,但长期随访后这一比例有所下降。
绝大多数Ⅱ级室管膜瘤患者可实现全切除并获得良好的神经功能预后;需要强调的是,IONM的使用可实现可接受的切除范围,并在功能预后方面提供更好的结果,发病率更低。因此,IONM的基础振幅和D波的降低与不良神经功能预后之间未显示出相关性。